Monsoon Season :Pregnant women and their children must be cared for
By,Dr.Vimala Kumari, MBBS, MD(Obstetrics & Gynecology), DRME, ISOM (MUNICH), Ankura Hospital for women & children It’s that time of year...
Category : HEALTH NINJA
National Doctors’ Day:History and Importance
by Riaan Desk
The Indian Medical Association observes National Doctors’ Day on July 1 each year (IMA). The day is marked to remember...
Delhi AIIMS to start Covaxin trial on children from Tuesday
by Riaan Desk
The All India Institute of Medical Sciences (AIIMS) is learnt to possess started screening children aged 6-12 years for the...
Doctors Mark “Black Day” Against “Allopathy Killed Lakhs” Remark
by Riaan Desk
Doctors across the country are observing a “Black Day” today in protest against Yoga guru Ramdev’s alleged remarks on...
Hype and sensationalism detrimental amidst COVID
by Riaan Desk
Right communication is undoubtedly is indispensable to make one alert and prepared to counter any catastrophic incidents. In the case...
Arjas Steel partners with Anantapur District Administration to set up a 500 bed Covid hospital
by Riaan Desk
Specialty steel manufacturer Arjas Steel in partnership with the Anantapur District Administration, has made a 500 bed Covid Care Hospital...
Vaccination is the only effective way to fight and end the pandemic:MP Chief Minister
by Riaan Desk
Mr Shivraj Singh Chouhan, Chief Minister, Madhya Pradesh today urged the industry to come forward in vaccinating the citizens. He...
COVID-19:Third wave – do we need to fear it?
by Riaan Desk
The country is currently witnessing the consequences of ignoring the warnings of an imminent second wave from scientists, doctors, and...
Anti Covid drug 2-DG launched by Defence Minister and Health Minister
by Riaan Desk
Minister of Defence, Shri Rajnath Singh and Minister of Health and Family Welfare, Dr. Harsh Vardhan today jointly launched the...
COVID-19 vaccine for 2-18 years | Covaxin to start out Phase 2/3 clinical trials
by Riaan Desk
Bharat Biotech’s vaccine against COVID-19, Covaxin, has been recommended by an expert panel for phase 2/3 clinical trials on 2-18-year-olds,...